Brief: Monash IVF Revises FY25 Underlying NPAT Guidance To A$27.5 Mln
20/05/2025 02:25
May 20 (Reuters) - Monash IVF Group Ltd MVF.AX: REVISES FY25 UNDERLYING NPAT GUIDANCE TO A$27.5M Further company coverage: MVF.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monash IVF
See all newsBrief: Monash IVF Group Appoints Matt Harrington As Chief Financial Officer
Australia's Monash IVF at over four-month high on upbeat FY27 outlook
Brief: Monash IVF Group Posts FY Revenue AUD 269.5 Million
Brief: Monash IVF Group Appoints Catherine West As Chair-Elect
Brief: Memphasys Executes Supply Agreement With Monash IVF Group